Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 3/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.46 |
| ▸ | FDPS | P14324 | 11/20 | 0.43 |
| ▸ | ESR1 | P03372 | 3/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2032074 | 0.85 | FDPS (0.46) | FDPSESR1ESR2GGPS1 | |
| SCHEMBL11406548 | 0.84 | PTPN1 (0.46) | FDPSMEN1ALDH1A1KMT2AGGPS1 | |
| SCHEMBL11759783 | 0.81 | PTPN1 (0.46) | FDPSESR1ESR2GGPS1 | |
| SCHEMBL6769521 | 0.81 | FDPS (0.42) | FDPSESR1ESR2GGPS1 | |
| SCHEMBL28418733 | 0.80 | GGPS1 (0.49) | HDAC1HDAC3HDAC2FDPSGGPS1 | |
| SCHEMBL11411164 | 0.80 | GGPS1 (0.49) | FDPSGGPS1 | |
| SCHEMBL11475619 | 0.79 | FDPS (0.47) | FDPSGGPS1 | |
| SCHEMBL11413454 | 0.78 | GGPS1 (0.50) | FDPSGGPS1 | |
| SCHEMBL11418608 | 0.78 | GGPS1 (0.50) | FDPSGGPS1 | |
| SCHEMBL11764166 | 0.76 | GGPS1 (0.47) | FDPSGGPS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070120113-A1 | Supramolecular structures and method for forming the same | NATIONAL TAIWAN UNIVERSITY (TW) | 2007-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070120113-A1 | Supramolecular structures and method for forming the same | RDX, NBAS, SOD1 | HDAC1 3939/4885HDAC3 3485/4885HDAC2 4332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.